Optimized dengue virus entry inhibitory peptide (DN81)
A technology for dengue virus, entry inhibitors, domain-binding inhibitors, in vivo antiviral compound candidates, for the treatment of diseases induced by dengue viruses
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0019] One embodiment of the present invention relates to a method for inhibiting dengue infection, comprising inhibiting the fusion of the virion envelope with the cell membrane, and delivering the viral genome into the cytoplasm.
[0020] According to the present invention, any peptide or protein (including those dengue viruses that infect human as well as non-human hosts) that inhibits the fusion of the dengue virus envelope with the cell membrane can be used. In various embodiments of the invention, these dengue peptide entry inhibitors may include, but are not limited to, peptides associated with membrane-interacting binding regions of several dengue virus proteins. The genome structure of dengue virus is as figure 1 shown.
[0021] The term "binding region", when applied to a peptide, nucleic acid, complex, etc., refers to a region of the dengue virus E protein or other class II E protein that is a target or likely to bind an agent that reduces or inhibits viral infecti...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com